Inventor · disambiguated record
Yan Zhang
Also filed as: ZHANG YAN · Zhang yan-liang
9 granted patents·7 pending applications·82 citations·filing 1995–2025
86Inventor score
Files withSORRENTO THERAPEUTICS INC4BASF ENZYMES LLC3CAPSTAN THERAPEUTICS INC2HUGHES HOWARD MED INST2BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
16 records- 0192US8343747B2Amylases and glucoamylases, nucleic acids encoding them and methods for making and using themVERENIUM CORP·Filed 2007·Granted Jan 1, 2013·32 cites·6 claims
- 0291US10377827B2Antigen binding proteins that bind c-metSORRENTO THERAPEUTICS INC·Filed 2013·Granted Aug 13, 2019·14 cites·6 claims
- 0385US10100299B2Amylases and glucoamylases, nucleic acids encoding them and methods for making and using themBASF ENZYMES LLC·Filed 2012·Granted Oct 16, 2018·4 cites·4 claims
- 0474US11739312B2Amylases and glucoamylases, nucleic acids encoding them and methods for making and using themBASF ENZYMES LLC·Filed 2020·Granted Aug 29, 2023·0 cites·28 claims
- 0574US5876949AAntibodies specific for fragile X related proteins and method of using the sameUNIV PENNSYLVANIA·Filed 1995·Granted Mar 2, 1999·31 cites·9 claims
- 0673US2025123272A1GENETICALLY ENCODED CALCIUM INDICATORS (GECIs) AND METHODS OF MAKING AND USINGHUGHES HOWARD MED INST·Filed 2024·Application pending·0 cites
- 0771US11155628B2Antigen binding proteins that bind c-MetSORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·0 cites·18 claims
- 0869US2022002422A1Antigen Binding Proteins that Bind c-MetSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0967US12044675B2Genetically encoded calcium indicators (GECIs) and methods of making and usingHUGHES HOWARD MED INST·Filed 2021·Granted Jul 23, 2024·0 cites·25 claims
- 1066US10883098B2Amylases and glucoamylases, nucleic acids encoding them and methods for making and using themBASF ENZYMES LLC·Filed 2018·Granted Jan 5, 2021·0 cites·12 claims
- 1162US2025152628A1Tcr targeting cytomegalovirus antigen, t cell expressing tcr, and applicationSHANGHAI GENERAL HOSPITAL·Filed 2022·Application pending·0 cites
- 1261US9429581B2IP-10 antibody dosage escalation regimensBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·1 cites·13 claims
- 1358US2025144234A1RNA for In vivo Transfection with Increased ExpressionCAPSTAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1440US2025302763A1Immune engineering amplificationCAPSTAN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1535US2014065164A1Ip-10 antibody dosage escalation regimensLUO ALLISON Y·Filed 2012·Application pending·0 cites
- 1634US2017112878A1Programmable universal cell receptors and method of using the sameSORRENTO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yan Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →